NMR Structure Implications of Enhanced Efficacy of Obestatin Fragment Analogs

Obestatin is a more recently discovered hormone that is encoded by the ghrelin gene and produced in the stomach and gut. We report NMR analysis on synthetic Obestatin (OB23), a 23 residue peptide, along with three overlapping fragments of the same in methanol solvent as a first step towards structur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of peptide research and therapeutics 2011-12, Vol.17 (4), p.259-270
Hauptverfasser: Krishnarjuna, B., Ganjiwale, Anjali D., Manjappara, Uma V., Raghothama, S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 270
container_issue 4
container_start_page 259
container_title International journal of peptide research and therapeutics
container_volume 17
creator Krishnarjuna, B.
Ganjiwale, Anjali D.
Manjappara, Uma V.
Raghothama, S.
description Obestatin is a more recently discovered hormone that is encoded by the ghrelin gene and produced in the stomach and gut. We report NMR analysis on synthetic Obestatin (OB23), a 23 residue peptide, along with three overlapping fragments of the same in methanol solvent as a first step towards structure activity relationship. Selective substitutions on the promising N-terminal and middle fragments of obestatin have been carried out in order to improve the efficacy and potency. In the N-terminal fragment two peptides were obtained by the replacement of Gly (8) with α-aminoisobutyric acid (Aib, U) and Phe (F5) with Cyclohexylalanine (Cha). In case of the middle fragment both Gly (3) and Gly (8) were replaced with Aib residues. The rationale being, these unusual amino acids could provide protection from immediate degradation and aid structure stabilization. Our previous studies showed that the N-terminal and the middle fragment were unstructured and hence this substitution would directly evaluate the effect of structure on the activity of these fragment analogs. Detailed NMR analysis clearly demonstrates formation of helical secondary structure in all the peptide analogues and provides justification for relative activities reported by our group previously (Nagaraj et al. 2009 ).
doi_str_mv 10.1007/s10989-011-9266-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_898703402</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2487757031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-eebad1cbc1c4fd0a610a424501e88f72484ff49d7772889fdf2e277575f69def3</originalsourceid><addsrcrecordid>eNp1kE9PAjEUxBujiYh-AG8b76vvdbvb9kgICAlI4p9zU7otQqCL7e6Bb2_Jajx5ei-T30wmQ8g9wiMC8KeIIIXMATGXtKpycUEGWPIiLySwy98fmbwmNzHuAErKEQZk-bJ8zd7a0Jm2CzabH477rdHttvExa1w28Z_aG1tnE-eSbk5ncbW2sU2Mz6ZBbw7Wt9nI632zibfkyul9tHc_d0g-ppP38SxfrJ7n49EiNwWWbW7tWtdo1gYNczXoCkEzykpAK4TjlAnmHJM155wKIV3tqKWcl7x0laytK4bkoc89huarS23UrulC6hCVkIJDwYAmCHvIhCbGYJ06hu1Bh5NCUOfRVD-aSqOp82hKJA_tPTGxfmPDX_D_pm-5Sm8R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>898703402</pqid></control><display><type>article</type><title>NMR Structure Implications of Enhanced Efficacy of Obestatin Fragment Analogs</title><source>SpringerLink Journals - AutoHoldings</source><creator>Krishnarjuna, B. ; Ganjiwale, Anjali D. ; Manjappara, Uma V. ; Raghothama, S.</creator><creatorcontrib>Krishnarjuna, B. ; Ganjiwale, Anjali D. ; Manjappara, Uma V. ; Raghothama, S.</creatorcontrib><description>Obestatin is a more recently discovered hormone that is encoded by the ghrelin gene and produced in the stomach and gut. We report NMR analysis on synthetic Obestatin (OB23), a 23 residue peptide, along with three overlapping fragments of the same in methanol solvent as a first step towards structure activity relationship. Selective substitutions on the promising N-terminal and middle fragments of obestatin have been carried out in order to improve the efficacy and potency. In the N-terminal fragment two peptides were obtained by the replacement of Gly (8) with α-aminoisobutyric acid (Aib, U) and Phe (F5) with Cyclohexylalanine (Cha). In case of the middle fragment both Gly (3) and Gly (8) were replaced with Aib residues. The rationale being, these unusual amino acids could provide protection from immediate degradation and aid structure stabilization. Our previous studies showed that the N-terminal and the middle fragment were unstructured and hence this substitution would directly evaluate the effect of structure on the activity of these fragment analogs. Detailed NMR analysis clearly demonstrates formation of helical secondary structure in all the peptide analogues and provides justification for relative activities reported by our group previously (Nagaraj et al. 2009 ).</description><identifier>ISSN: 1573-3149</identifier><identifier>EISSN: 1573-3904</identifier><identifier>DOI: 10.1007/s10989-011-9266-8</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Amino acids ; Animal Anatomy ; Biochemistry ; Biomedical and Life Sciences ; Histology ; Hormones ; Life Sciences ; Molecular Medicine ; Morphology ; NMR ; Nuclear magnetic resonance ; Peptides ; Pharmaceutical Sciences/Technology ; Pharmacology/Toxicology ; Polymer Sciences</subject><ispartof>International journal of peptide research and therapeutics, 2011-12, Vol.17 (4), p.259-270</ispartof><rights>Springer Science+Business Media, LLC 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-eebad1cbc1c4fd0a610a424501e88f72484ff49d7772889fdf2e277575f69def3</citedby><cites>FETCH-LOGICAL-c315t-eebad1cbc1c4fd0a610a424501e88f72484ff49d7772889fdf2e277575f69def3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10989-011-9266-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10989-011-9266-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids></links><search><creatorcontrib>Krishnarjuna, B.</creatorcontrib><creatorcontrib>Ganjiwale, Anjali D.</creatorcontrib><creatorcontrib>Manjappara, Uma V.</creatorcontrib><creatorcontrib>Raghothama, S.</creatorcontrib><title>NMR Structure Implications of Enhanced Efficacy of Obestatin Fragment Analogs</title><title>International journal of peptide research and therapeutics</title><addtitle>Int J Pept Res Ther</addtitle><description>Obestatin is a more recently discovered hormone that is encoded by the ghrelin gene and produced in the stomach and gut. We report NMR analysis on synthetic Obestatin (OB23), a 23 residue peptide, along with three overlapping fragments of the same in methanol solvent as a first step towards structure activity relationship. Selective substitutions on the promising N-terminal and middle fragments of obestatin have been carried out in order to improve the efficacy and potency. In the N-terminal fragment two peptides were obtained by the replacement of Gly (8) with α-aminoisobutyric acid (Aib, U) and Phe (F5) with Cyclohexylalanine (Cha). In case of the middle fragment both Gly (3) and Gly (8) were replaced with Aib residues. The rationale being, these unusual amino acids could provide protection from immediate degradation and aid structure stabilization. Our previous studies showed that the N-terminal and the middle fragment were unstructured and hence this substitution would directly evaluate the effect of structure on the activity of these fragment analogs. Detailed NMR analysis clearly demonstrates formation of helical secondary structure in all the peptide analogues and provides justification for relative activities reported by our group previously (Nagaraj et al. 2009 ).</description><subject>Amino acids</subject><subject>Animal Anatomy</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Histology</subject><subject>Hormones</subject><subject>Life Sciences</subject><subject>Molecular Medicine</subject><subject>Morphology</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Peptides</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology/Toxicology</subject><subject>Polymer Sciences</subject><issn>1573-3149</issn><issn>1573-3904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kE9PAjEUxBujiYh-AG8b76vvdbvb9kgICAlI4p9zU7otQqCL7e6Bb2_Jajx5ei-T30wmQ8g9wiMC8KeIIIXMATGXtKpycUEGWPIiLySwy98fmbwmNzHuAErKEQZk-bJ8zd7a0Jm2CzabH477rdHttvExa1w28Z_aG1tnE-eSbk5ncbW2sU2Mz6ZBbw7Wt9nI632zibfkyul9tHc_d0g-ppP38SxfrJ7n49EiNwWWbW7tWtdo1gYNczXoCkEzykpAK4TjlAnmHJM155wKIV3tqKWcl7x0laytK4bkoc89huarS23UrulC6hCVkIJDwYAmCHvIhCbGYJ06hu1Bh5NCUOfRVD-aSqOp82hKJA_tPTGxfmPDX_D_pm-5Sm8R</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Krishnarjuna, B.</creator><creator>Ganjiwale, Anjali D.</creator><creator>Manjappara, Uma V.</creator><creator>Raghothama, S.</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20111201</creationdate><title>NMR Structure Implications of Enhanced Efficacy of Obestatin Fragment Analogs</title><author>Krishnarjuna, B. ; Ganjiwale, Anjali D. ; Manjappara, Uma V. ; Raghothama, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-eebad1cbc1c4fd0a610a424501e88f72484ff49d7772889fdf2e277575f69def3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Amino acids</topic><topic>Animal Anatomy</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Histology</topic><topic>Hormones</topic><topic>Life Sciences</topic><topic>Molecular Medicine</topic><topic>Morphology</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Peptides</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology/Toxicology</topic><topic>Polymer Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krishnarjuna, B.</creatorcontrib><creatorcontrib>Ganjiwale, Anjali D.</creatorcontrib><creatorcontrib>Manjappara, Uma V.</creatorcontrib><creatorcontrib>Raghothama, S.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of peptide research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krishnarjuna, B.</au><au>Ganjiwale, Anjali D.</au><au>Manjappara, Uma V.</au><au>Raghothama, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NMR Structure Implications of Enhanced Efficacy of Obestatin Fragment Analogs</atitle><jtitle>International journal of peptide research and therapeutics</jtitle><stitle>Int J Pept Res Ther</stitle><date>2011-12-01</date><risdate>2011</risdate><volume>17</volume><issue>4</issue><spage>259</spage><epage>270</epage><pages>259-270</pages><issn>1573-3149</issn><eissn>1573-3904</eissn><abstract>Obestatin is a more recently discovered hormone that is encoded by the ghrelin gene and produced in the stomach and gut. We report NMR analysis on synthetic Obestatin (OB23), a 23 residue peptide, along with three overlapping fragments of the same in methanol solvent as a first step towards structure activity relationship. Selective substitutions on the promising N-terminal and middle fragments of obestatin have been carried out in order to improve the efficacy and potency. In the N-terminal fragment two peptides were obtained by the replacement of Gly (8) with α-aminoisobutyric acid (Aib, U) and Phe (F5) with Cyclohexylalanine (Cha). In case of the middle fragment both Gly (3) and Gly (8) were replaced with Aib residues. The rationale being, these unusual amino acids could provide protection from immediate degradation and aid structure stabilization. Our previous studies showed that the N-terminal and the middle fragment were unstructured and hence this substitution would directly evaluate the effect of structure on the activity of these fragment analogs. Detailed NMR analysis clearly demonstrates formation of helical secondary structure in all the peptide analogues and provides justification for relative activities reported by our group previously (Nagaraj et al. 2009 ).</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10989-011-9266-8</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1573-3149
ispartof International journal of peptide research and therapeutics, 2011-12, Vol.17 (4), p.259-270
issn 1573-3149
1573-3904
language eng
recordid cdi_proquest_journals_898703402
source SpringerLink Journals - AutoHoldings
subjects Amino acids
Animal Anatomy
Biochemistry
Biomedical and Life Sciences
Histology
Hormones
Life Sciences
Molecular Medicine
Morphology
NMR
Nuclear magnetic resonance
Peptides
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Polymer Sciences
title NMR Structure Implications of Enhanced Efficacy of Obestatin Fragment Analogs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T02%3A21%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NMR%20Structure%20Implications%20of%20Enhanced%20Efficacy%20of%20Obestatin%20Fragment%20Analogs&rft.jtitle=International%20journal%20of%20peptide%20research%20and%20therapeutics&rft.au=Krishnarjuna,%20B.&rft.date=2011-12-01&rft.volume=17&rft.issue=4&rft.spage=259&rft.epage=270&rft.pages=259-270&rft.issn=1573-3149&rft.eissn=1573-3904&rft_id=info:doi/10.1007/s10989-011-9266-8&rft_dat=%3Cproquest_cross%3E2487757031%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=898703402&rft_id=info:pmid/&rfr_iscdi=true